B Vitamins: Everything Science Proves (and Debunks) in 2026

B Vitamins

The 8 B vitamins in active forms: Quatrefolic® folate, methylcobalamine, pyridoxal-5-phosphate, fermentation riboflavin. All at 100% of reference intakes or more. Made in France.

See B Vitamins →

The "B group" is not a chemical family. These are eight distinct vitamins, brought together because they are water-soluble and act as cofactors in metabolism. Their target populations, however, have almost nothing in common.

Here is the table that's missing everywhere: for each vitamin, its authorized European claim, its best level of clinical evidence, and who is truly affected.

Two findings stand out. First, the regulatory claims all resemble each other, centered around energy metabolism and the nervous system, whereas the clinical evidence diverges radically from one vitamin to another. Second, a vitamin can have an authorized claim and weak clinical evidence, or vice versa: riboflavin carries a mundane claim about fatigue, yet the best trial concerning it focuses on migraine.

The regulatory filter to know

A claim can only be made if the product provides at least 15% of the reference nutritional values per serving. Below that, the presence of the vitamin is merely decorative. This is the first reflex when reviewing a complex: look at the percentages, not the length of the list.

Classical synthetic forms, folic acid, cyanocobalamin and pyridoxine, must be transformed before they can be used. Active forms, methylfolate, methylcobalamin and pyridoxal-5-phosphate, bypass these steps. This is a real criterion, but its clinical significance varies depending on the vitamin.

Folate, where the metabolic logic is clear

Folic acid must be reduced and then methylated to become 5-methyltetrahydrofolate, the form that circulates in plasma. This chain mobilizes two enzymes, including MTHFR, whose activity varies from individual to individual.

According to PubMed, a 2013 review by Seremak-Mrozikiewicz describes the calcium salt of L-5-methyltetrahydrofolate as entering directly into metabolism, without a reduction step, which makes it possible to bypass diminished enzymatic activity.

Honesty note: this source is old and published in a journal with limited circulation. The literature directly comparing methylfolate and folic acid on clinical outcomes is thinner than commercial discourse suggests. The argument rests on metabolic logic, not on clinically demonstrated superiority. It's also worth noting that all the major studies cited later on neural tube defects and stroke were conducted withclassical folic acid, which works.

Vitamin B6, where form touches on safety

This is where the question ceases to be theoretical. According to PubMed, a 2021 review by Hadtstein and Vrolijk published in Advances in Nutrition examines the mechanism of vitamin B6-induced neuropathies.

The point is noteworthy: PDXK is the enzyme that converts pyridoxine to pyridoxal-5-phosphate. The proposed toxicity mechanism therefore concerns the conversion step itself. This does not prove that the active form is risk-free, no study establishes this, but it provides a mechanistic reason to look into it.

It is this logic that guides the composition of our B Vitamins, with folate Quatrefolic®, methylcobalamine, pyridoxal-5-phosphate and fermentation-derived riboflavin.

This is the pinnacle of the evidence pyramid for the entire B group. Folate supplementation before conception reduces the risk of neural tube defects by 69% . And 400 µg per day is sufficient : subgroup analyses show no additional benefit beyond this.

What the same review does not show

For the sake of rigor, we must state what is not proven. The review finds no significant effect on other congenital malformations, cleft lip and palate or cardiovascular malformations, nor on miscarriages. Folate prevents one specific malformation, not pregnancy in general.

The time factor, decisive

The neural tube closes within the first four weeks, often before pregnancy is known. Hence the recommendation periconceptional : to begin before conception. Supplementation started in the second month comes after the critical window.

Our Vitamin B provide 400 µg of folates, the exact dose used in the review analyses.

This is the most underestimated result in the B group, and it concerns hard clinical endpoint, not an intermediate marker. Folic acid supplementation reduces the risk ofstroke, and the effect is confirmed by two independent analyses of very large scale.

A second analysis, of even larger scale, converges. According to PubMed, An et al. 2022 in the Journal of the American College of Cardiology conducted a systematic review of 884 randomized trials involving 883,627 participants and 27 micronutrients. Folic acid emerges as reducing stroke risk (RR 0.84), alongside omega-3 and coenzyme Q10, while vitamins C, D and E and selenium show no cardiovascular effect ([DOI: 10.1016/j.jacc.2022.09.048]).

The nuances that matter

Three clarifications make this result actionable rather than just a slogan.

The benefit applies tostroke, not coronary heart disease, where the analysis finds nothing. This is an important distinction: B vitamins are not a general cardiovascular treatment.

The effect is more pronounced in people whose plasma folate levels are low at baseline, and in those without preexisting cardiovascular disease. Once again, we are correcting a deficiency rather than improving an optimal state.

Finally, the reduction is 10%, which is modest at the individual level but significant at the population level, stroke being a major cause of acquired disability.

Riboflavin is marketed for fatigue and vision. Its best clinical outcome is elsewhere: migraine prevention, at high dose, with a remarkable benefit-to-risk ratio and a number-needed-to-treat of only 2.3.

A number needed to treat of 2.3 means that treating slightly more than two people is sufficient for one of them to see their seizures reduced by half. This is a high figure for a nutritional intervention, and the authors emphasize its excellent tolerance and low cost.

The signal is confirmed more recently. According to PubMed, a network meta-analysis published in 2024 in JAMA Network Open, covering 45 trials and 3,771 participants with pediatric migraine, found riboflavin among treatments associated with a reduction in seizure frequency, with the caveat that this result comes from individual studies and requires confirmation ([DOI: 10.1001/jamanetworkopen.2024.38666]).

Vitamin B6, combined with doxylamine, constitutes an established medication option against nausea and vomiting of pregnancy. It is one of the rare B group indications appearing in routine clinical practice.

Two reservations that the authors themselves formulate. The magnitude of the effect is modest, and an increased risk of small-for-gestational-age newborns was observed with the doxylamine-pyridoxine combination in this trial.

It should also be emphasized that this is a medication combining B6 and antihistamine, prescribed and medically monitored. A B vitamin complex is not its equivalent, and the management of pregnancy nausea falls to the physician or midwife.

B12 is produced by bacteria and found in animal products. No non-fortified plant contains a usable form of it. Three situations lead to deficiency: theabsence of intake in vegans, the decreased absorption with age, and themedication interference, primarily with metformin.

Plant-based diets

The most useful finding is from the subgroup analysis: the difference disappears in supplemented vegans. A second meta-analysis, involving largely vegetarian Adventist populations, confirms the absence of difference with omnivores when fortified foods and supplements are used ([DOI : 10.1177/08901171241273330]).

Metformin, with precise figures

This is a point rarely explained to affected patients, yet there are many of them.

Risk therefore increases with duration and with dose. The authors conclude that supplementation may be beneficial in these patients, which should be discussed with the prescribing physician rather than undertaken as an isolated decision.

Age

B12 requires the intrinsic factor produced by the stomach for absorption. With age, the decline in gastric acidity and reduction in this production decrease absorption, even when dietary intake remains adequate. Long-term treatment with proton pump inhibitors has the same effect.

A note of transparency on dosages

Our B Vitamins provide 2.5 µg of B12, or 100% of the reference intake, which corresponds to covering common needs in the general population.

However, absorption via the intrinsic factor is saturable. A strict long-term vegan, an elderly person with malabsorption, or a patient on long-term metformin typically require significantly higher dosages, determined with a healthcare professional. A balanced complex addresses basic needs: it is not designed to correct an established deficiency.

This is the most clinically important point of this entire article. B12 deficiency can cause nervous system damage, and this damage is potentially reversible with treatment. That said, it must be identified, which is far from systematic.

Two major lessons. First, neurological manifestations can be the first and sometimes the only sign of a deficiency, before any visible blood abnormality. Next, and this is striking, serum B12 was low in only four patients out of nine, yet all responded to treatment.

The authors therefore recommend systematically ruling out B12 deficiency in cases of unexplained neuropathy, precisely because it is reversible. Six out of nine patients improved in less than one month.

Serum B12 concentration is the most commonly prescribed marker and one of the least reliable when taken in isolation. Three complementary markers clarify the picture:homocysteine,methylmalonic acid , andholotranscobalamin.

The two previous sections demonstrate this in two different ways. In vegans, the most marked difference involved elevated homocysteine and low holotranscobalamin, markers of functional deficiency. And in the series of neuropathic patients, serum B12 was normal in five out of nine people who nevertheless responded to treatment.

What each marker measures

Holotranscobalamincorresponds to the fraction of B12 actually available to cells, representing a minority portion of circulating B12. Methylmalonic acid andhomocysteine accumulate when B12 is lacking at the cellular level: these arefunctional markers ., which reflect a metabolic blockage rather than a quantity.

In other words, serum B12 measures what circulates, not what is working. The practical consequence: a result "within normal range" does not close the question in a person at risk or symptomatic. The choice of additional tests belongs to the physician.

This limitation also explains part of the heterogeneity of clinical trials on B vitamins: they often include people classified as non-deficient based solely on serum dosage, while their functional status may have been insufficient.

This is the most marketed claim of the B group, and it deserves to be clarified rather than dismissed. B vitamins provide no calories : they serve as cofactors for enzymes that convert nutrients into usable energy. But a well-designed randomized trial shows measurable benefit on physical and mental endurance, with an illuminating methodological detail.

The detail that changes the reading

The benefits on concentration and mental endurance appear in the assessment conducted after a day of work, and not in the one conducted before. This is exactly what we expect from a metabolic cofactor: it does not create energy, it allows the body to better sustain the load.

The honest formulation is therefore as follows: a B vitamin complex is not a stimulant and does not provide a quick boost. It supports functioning when the body is under stress. Note that the study involved a complex combined with vitamin C and minerals, and that physical endurance was self-reported, not measured by exercise testing.

What the regulation says exactly

The authorized claims are formulated with a precision that is not merely decorative: « contributes to normal energy metabolism » and « contributes to reducing fatigue ». The word normal signals a return to expected functioning.

As for the word vitality, heavily used commercially, it has no regulatory or scientific definition. The closest equivalent in the literature is physical endurance as self-reported and measured by Kennedy.

The practical conclusion remains the one that runs through this entire report: the benefit is clear when a deficit is corrected, and subtle when the status is already adequate.

Unlike many so-called anti-stress supplements, stress here was actually measured, and it is improving. But the analysis separates three things that are constantly conflated: stress improves significantly, while depressive symptoms do not reach significance, andanxiety does not change at all.

Stress and anxiety are not the same thing

This is the distinction that marketing systematically erases. Stress is a response to an identifiable external constraint, with a physiological component.Anxiety is a state of apprehension that can exist without a trigger and sometimes falls into the clinical category.

The data clearly separate the two: measurable benefit on the first, complete absence of effect on the second. A B vitamin complex therefore in no way replaces the treatment of an anxiety disorder.

Let us also clarify the effect size: an SMD of 0.23 corresponds to a small effect. It is real, it is measured, it is not spectacular. And the benefit primarily concerns individuals whose nutritional status or mood are already compromised.

From a regulatory standpoint, the permissible claims are those of normal functioning of the nervous system and normal psychological functions, which describes a physiological contribution and not an anxiolytic effect.

B vitamins effectively lowerhomocysteine, that is consensus. Whether this reduction translates into a cognitive benefit is, however, openly contested.

What Sets Them Apart

The divergence stems from conditions that the abstracts obscure. The favorable analysis finds an effect only in two situations: interventions lasting more than 12 months, and populations not yet affected by dementia. In short-term trials, or in people already affected, the effect disappears.

Another nuance from this same analysis: it is folate that stands out specifically, with high dietary intake being associated with a reduced risk of dementia, whereas this is not the case for either B12 or B6.

A third finding, counter-intuitive

A randomized trial published in 2022 sheds unexpected light on short-term mental clarity.

No benefit across the entire cohort, but a benefit on attention and mental fatigue in participants who already had a good quality diet, contrary to the authors' hypothesis. They discuss co-optimization of nutrients : B vitamins work better when the rest of the nutritional foundation is favorable. Important caveat to note: one author is affiliated with a supplement manufacturer.

The overall reading is therefore nuanced. Regarding mental clarity, we have a consistent signal, supported by Kennedy on late-day concentration and by Young on mental fatigue, but not a solid demonstration. And on prevention of long-term cognitive decline, the issue remains unresolved. Presenting a B-complex vitamin as proven prevention of dementia would go far beyond the available data.

Two claims do not withstand scrutiny. The biotin for hair in healthy individuals, despite a considerable market. And thiamine in heart failure, where a well-conducted randomized trial finds no benefit.

Biotin, the Best-Selling Myth

The authorized claim states that biotin "contributes to the maintenance of normal hair." But contributing to maintenance is not promoting growth, and "normal" is not "more beautiful." Add to this that biotin deficiency is rare in a normal diet, the vitamin being widely distributed and partially produced by the intestinal microbiota.

Thiamine and heart failure

The hypothesis was attractive: since thiamine is involved in cellular energy production, and deficiency is common in heart failure, supplementation could have improved heart function. The trial was conducted, and it was negative.

The detail is instructive: thiamine concentrations did increase in the supplemented group. The product did what was expected on the biological level, without this translating clinically. It is the clearest reminder that correcting a marker is not enough to improve an outcome.

This takes nothing away from the role of thiamine in case of true deficiency, particularly in contexts of regular alcohol consumption, where its deficiency has serious and well-established neurological consequences.

Niacin, a conditional benefit

The case of B3 illustrates a third situation, neither positive nor negative. According to PubMed, a meta-analysis by Maki et al. 2016 shows that treatments lowering triglycerides, including niacin, reduce the risk of cardiovascular events in people with elevated triglycerides, with an even clearer benefit if HDL is low ([DOI: 10.1016/j.jacl.2016.03.008]). In the general population, however, trials have not shown consistent benefit.

Again, the effect depends on the baseline profile. And these are uses at pharmacological doses, under medical supervision, unrelated to the few milligrams in a balanced complex.

B vitamins are water-soluble : excess is largely eliminated through urine, which significantly limits the risk of accumulation. One clear exception stands out: vitamin B6, whose prolonged excess is associated with peripheral sensory neuropathies.

As seen in section 2, the review by Hadtstein and Vrolijk establishes that supplements containing pyridoxine have been linked to the development of neuropathies, through preferential damage to sensory neurons, with an increasing number of reported cases.

Two useful clarifications: the documented toxicity concerns high and prolonged intakes, not the doses found in a balanced complex. And the proposed mechanism involves inhibition of the conversion enzyme, which potentially distinguishes pyridoxine from the already active form.

Other points of attention

<<<15>>> Niacin niacine at high doses can cause transient skin flushing, the "flush," which is unpleasant but harmless. Biotin interferes with certain blood tests. Finally, supplementation with folates can correct anemia linked to B12 deficiency while allowing neurological damage to progress, which is a serious reason not to self-supplement with folates alone when a risk of B12 deficiency exists.

For a complete clinical framework, the ESPEN micronutrient guideline, which covers 26 micronutrients through 170 recommendations, is the reference in clinical nutrition ([DOI: 10.1016/j.clnu.2022.02.015]).

All the data in this article converge toward one rule: the benefits are clear in people presenting with a deficit, risk, or vulnerability, and modest in those whose status is already adequate. Identifying your profile is better than comparing labels.

FAQ, all your questions about B vitamins